Foghorn Therapeutics (FHTX) Prepaid Assets (2019 - 2026)
Foghorn Therapeutics (FHTX) recorded quarterly Prepaid Assets of $3.2 million in Q1 2026, up 2.98% quarter-over-quarter from $3.1 million in Q4 2025, and down 34.09% on a YoY basis from $4.8 million in Q1 2025.
Foghorn Therapeutics (FHTX) Prepaid Assets (2019 - 2026) Analysis & Trends
Foghorn Therapeutics' Prepaid Assets history runs 8 years deep, the most recent figure standing at $3.2 million for Q1 2026.
- In Q1 2026, Prepaid Assets fell 34.09% year-over-year to $3.2 million; the TTM figure through Mar 2026 stood at $3.2 million (down 34.09% YoY), while the FY2025 annual figure was $3.1 million, down 47.2% from the prior year.
- Prepaid Assets was $3.2 million for Q1 2026 at Foghorn Therapeutics, up from $3.1 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $6.2 million in Q2 2023 to a low of $2.6 million in Q3 2025.
- Historically, Prepaid Assets has averaged $4.7 million across 5 years, with a median of $4.8 million in 2025.
- The sharpest annual moves came in 2022 and 2025: Prepaid Assets soared 57.02% in 2022, then sank 47.2% in 2025.
- A 5-year view of Prepaid Assets shows it stood at $5.6 million in 2022, then increased by 9.34% to $6.1 million in 2023, then declined by 4.41% to $5.9 million in 2024, then tumbled by 47.2% to $3.1 million in 2025, then gained by 2.98% to $3.2 million in 2026.
- The last three Prepaid Assets figures came in at $3.2 million (Q1 2026), $3.1 million (Q4 2025), and $2.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Foghorn Therapeutics | 282.33 Mn | 193.42 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.18 Mn |
| Dec 31, 2025 | 3.09 Mn |
| Sep 30, 2025 | 2.59 Mn |
| Jun 30, 2025 | 3.93 Mn |
| Mar 31, 2025 | 4.83 Mn |
| Dec 31, 2024 | 5.85 Mn |
| Sep 30, 2024 | 3.84 Mn |
| Jun 30, 2024 | 4.44 Mn |
| Mar 31, 2024 | 4.86 Mn |
| Dec 31, 2023 | 6.12 Mn |
| Sep 30, 2023 | 5.55 Mn |
| Jun 30, 2023 | 6.18 Mn |
| Mar 31, 2023 | 4.73 Mn |
| Dec 31, 2022 | 5.60 Mn |
| Sep 30, 2022 | 4.24 Mn |
| Jun 30, 2022 | 5.34 Mn |
| Mar 31, 2022 | 5.09 Mn |
| Dec 31, 2021 | 5.27 Mn |
| Sep 30, 2021 | 3.11 Mn |
| Jun 30, 2021 | 3.40 Mn |